More on VRTX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $441.74 |
|
|||
| Open | $445.61 | ||||
| 52 Wk High | $134.71 | ||||
| 52 Wk Low | $73.31 | ||||
| Day High | $453.16 | ||||
| Day Low | $443.86 | ||||
| P/E | N/A | ||||
| EPS | $-1.98 | ||||
| Volume | 1,530,107 | ||||
- Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
- Vertex presents positive data for ALYFTREK in young cystic fibrosis patients
- Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference
- Form 4 VERTEX PHARMACEUTICALS For: Jun 01 Filed by: Liu Joy
- Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10
- Form 4 VERTEX PHARMACEUTICALS For: May 29 Filed by: Bozic Carmen
- Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy
- Vertex gets FDA acceptance for IgA nephropathy drug application
- Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy
- Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen
Entities mentioned with VRTX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Maynard Um | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
